Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.7556
+0.0220 (3.00%)
At close: Aug 14, 2026, 4:00 PM EDT
0.6801
-0.0755 (-9.99%)
After-hours: Aug 14, 2026, 7:58 PM EDT
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $20.74 million as of August 14, 2026. Its market cap has decreased by -4.85% in one year.
Market Cap
20.74M
Enterprise Value
16.96M
1-Year Change
-4.85%
Ranking
Category
Stock Price
$0.76
ChartMarket Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $20.74M, a decrease of -32.43%. That is a compound annual growth rate of -4.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 20.74M | 28.84% |
| Dec 31, 2025 | 16.10M | -47.90% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
| Jul 6, 2017 | 30.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABVC BioPharma | 22.74M |
| Allarity Therapeutics | 21.80M |
| Cocrystal Pharma | 21.57M |
| Neuphoria Therapeutics | 20.92M |
| Cellectar Biosciences | 20.78M |
| Quantum BioPharma | 20.70M |
| Polyrizon | 20.55M |
| Celularity | 20.14M |